Clinical Trials Directory

Trials / Completed

CompletedNCT00637078

STITCH2 (Simplified Therapeutic Intervention to Control Hypertension and Hypercholesterolemia)

Evaluation of a Primary Treatment Algorithm Using Combination Therapy for the Management of Patients With Hypertension and Hypercholesterolemia

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
1,000 (actual)
Sponsor
University of Western Ontario, Canada · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to assess if the implementation of a treatment algorithm including initial treatment with a low dose diuretic/ACE-inhibitor or ARB combination and subsequently a low dose DHP-CCB/statin combination will improve the management of hypertension/hypercholesterolemia compared to guidelines-base management at family practices.

Detailed description

Utilization of fixed dose combination therapy has been advocated as an adherence-enhancing strategy and has been so recommended in the 2007 Canadian Hypertension Education Program (CHEP) recommendations. Further, in a previous study (STITCH) it was demonstrated that a simplified treatment algorithm utilizing initial therapy with a low dose fixed-dose combination therapy improved blood pressure control in hypertensive patients. However, the effectiveness of either a simplified treatment algorithm or the initial use of fixed dose combination therapies for 2 risk factors in hypertensive dyslipidemic patients has yet to be determined. Therefore, the current study is designed to determine whether utilization of a fixed dose combination hypertension/hypercholesterolemia therapy results in improved adherence, patient satisfaction as well as improved rates of reaching target LDL cholesterol and blood pressure.

Conditions

Interventions

TypeNameDescription
OTHERTreatment algorithm:caduet, Amlodipine, ACEI-ARB combo dose, a-blocker, b-blocker or spironolactone, dyslipidemic therapy with ezetamideinitial treatment with a low dose diuretic/ACE-inhibitor or ARB combination followed by a low dose DHP-CCB/statin combination

Timeline

Start date
2008-02-01
Primary completion
2010-06-01
Completion
2010-12-01
First posted
2008-03-17
Last updated
2012-06-14

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00637078. Inclusion in this directory is not an endorsement.